A Phase II Trial of Intensity-Modulated Proton Therapy for Incompletely Resected Craniopharyngioma and Observation for Craniopharyngioma After Radical Resection
St. Jude Children's Research Hospital
St. Jude Children's Research Hospital
Cedars-Sinai Medical Center
National Institutes of Health Clinical Center (CC)
InSightec
Copernicus Memorial Hospital
Virginia Commonwealth University
National Institutes of Health Clinical Center (CC)
University of Texas Southwestern Medical Center
University of Cincinnati
Massachusetts General Hospital
M.D. Anderson Cancer Center
InSightec
National Institutes of Health Clinical Center (CC)
Telix Pharmaceuticals (Innovations) Pty Limited
Institut Claudius Regaud
Massachusetts General Hospital
M.D. Anderson Cancer Center
Massachusetts General Hospital
University of Calgary
CNS Pharmaceuticals, Inc.
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
M.D. Anderson Cancer Center
Columbia University
Columbia University
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
Canadian Cancer Trials Group
Black Diamond Therapeutics, Inc.
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Ohio State University Comprehensive Cancer Center
National Cancer Institute (NCI)
Northwell Health
Montefiore Medical Center
M.D. Anderson Cancer Center
Alliance for Clinical Trials in Oncology
Seattle Children's Hospital
NaviFUS Corporation
Mayo Clinic
Novelwise Pharmaceutical Corporation
Iambic Therapeutics, Inc
Institut Claudius Regaud
Tango Therapeutics, Inc.
National Taiwan University Hospital
Case Comprehensive Cancer Center
NaviFUS Corporation
M.D. Anderson Cancer Center